Dhillon Jaspreet K, Shi Junxin, Janezic Alyssa, Wheeler Krista K, Xiang Henry, Leonard Julie C
1 The Ohio State University College of Medicine , Columbus, Ohio.
2 The Center for Injury Research and Policy and The Center for Pediatric Trauma Research , Nationwide Children's Hospital, Columbus, Ohio.
J Neurotrauma. 2017 Jun 15;34(12):2019-2026. doi: 10.1089/neu.2016.4774. Epub 2017 Mar 21.
The aim of this study was to provide accurate estimates and characterizations of children with spinal cord injuries (SCIs) and for the subset that are appropriate for inclusion in clinical trials. We identified children <18 years of age with SCI International Classifications of Diseases, Ninth Revision, Clinical Modification Codes (ICD-9-CM codes) from the 2006, 2009, and 2012 Kids' Inpatient Database. We excluded those with late effects, transfers to other hospitals, unspecified injury levels, and hospital stays <48 h. We then used conventional rationale to identify children who were eligible for SCI clinical trials. Over 3 years, 2484 children had SCI ICD-9-CM codes; 1342 had coding consistent with true SCI and 706 satisfied clinical trial inclusion criteria, yielding national estimates of 2013 and 1062, respectively. Of children with clinical trial eligible SCI, injuries were more common in the cervical region (66.1%), males (65.5%), older children (51.1% were 16-17 years old), and the South (49.8%). The majority were treated at urban teaching hospitals (84.6%); however, only 20.3% were treated at pediatric-specific centers. Of the 445 sample hospitals treating children with SCI, 66.3% treated just 1 child in the 3-year period. Children eligible for SCI clinical trials represented less than one third of children with SCI ICD-9-CM codes. These children were regionally localized to the South, with few receiving treatment at pediatric-specific centers or centers that frequently care for children with SCI. These findings highlight the importance of carefully assessing the national distribution of children with SCI, so that resources are appropriately allocated to optimize clinical care and research outcomes.
本研究的目的是对脊髓损伤(SCI)儿童进行准确的评估和特征描述,并确定适合纳入临床试验的亚组。我们从2006年、2009年和2012年的儿童住院数据库中,根据国际疾病分类第九版临床修订版编码(ICD - 9 - CM编码)识别出年龄小于18岁的SCI儿童。我们排除了有晚期效应、转至其他医院、损伤水平未明确以及住院时间小于48小时的儿童。然后,我们采用传统的标准来确定符合SCI临床试验条件的儿童。在3年时间里,有2484名儿童有SCI的ICD - 9 - CM编码;其中1342名儿童的编码与真正的SCI相符,706名儿童满足临床试验纳入标准,全国估计数分别为2013名和1062名。在符合临床试验条件的SCI儿童中,损伤在颈椎区域更为常见(66.1%),男性居多(65.5%),年龄较大的儿童(51.1%为16 - 17岁)以及南部地区(49.8%)。大多数儿童在城市教学医院接受治疗(84.6%);然而,只有20.3%在儿科专科医院接受治疗。在治疗SCI儿童的445家样本医院中,66.3%在3年期间仅治疗了1名儿童。符合SCI临床试验条件的儿童占ICD - 9 - CM编码的SCI儿童的比例不到三分之一。这些儿童在地域上集中在南部,很少在儿科专科医院或经常治疗SCI儿童的中心接受治疗。这些发现凸显了仔细评估SCI儿童全国分布情况的重要性,以便合理分配资源,优化临床护理和研究结果。